Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
07/2014
07/02/2014CN102048695B 一种制备用于体内递送药理活性物质的蛋白纳米粒的方法 In vivo delivery of a pharmacologically active substance a method for preparing protein nanoparticles
07/02/2014CN102046208B 包含转录因子诱饵作为活性成分的用于外部应用的组合物 Containing the transcription factor decoy as an active ingredient of compositions for external application
07/02/2014CN101802013B 人源化抗cd79b抗体和免疫偶联物及使用方法 Humanized antibodies and immunoconjugates of anti cd79b and methods of use thereof
07/02/2014CN101541346B 包含环状化合物的制剂 Formulation comprising a cyclic compound
07/01/2014US8765964 Fatty acid niacin conjugates and their uses
07/01/2014US8765822 Concentrated inverse latex, process for preparing it and industrial use thereof
07/01/2014US8765796 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
07/01/2014US8765685 Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)
07/01/2014US8765680 Method for administering omega-conopeptide
07/01/2014US8765675 Use of calcitonin in osteoarthritis
07/01/2014US8765665 Albumin-free factor VIII formulations
07/01/2014US8765652 Method of making a formulation for deactivating nucleic acids
07/01/2014US8765432 Targeted drug phosphorylcholine polymer conjugates
07/01/2014US8765195 Methods and compositions for increasing sex steroids and growth hormones
07/01/2014US8765189 Organophosphorous and multivalent metal compound compositions and methods
07/01/2014US8765187 Aqueous composition
07/01/2014US8765174 Chewable soft capsule
07/01/2014US8765161 Monomers and phase-separated biocompatible polymer compositions prepared therefrom for medical uses
07/01/2014US8765157 Topical skin composition comprising shea butter, jojoba oil, petroleum jelly, glycerin, and zinc oxide
07/01/2014US8765156 Topical compositions comprising inorganic particulates and an alkoxylated diphenylacrylate compound
07/01/2014US8765124 Stabilized preparation containing protein
07/01/2014US8765111 N-maleimidyl polymer derivatives
06/2014
06/27/2014CA2838193A1 Antioxidant for oils and fats
06/26/2014WO2014100797A1 Topical ophthalmological pharmaceutical composition containing regorafenib
06/26/2014WO2014100443A2 Methods of producing immunoconjugates
06/26/2014WO2014098887A1 Levothyroxine formulation with acacia
06/26/2014WO2014098886A1 Levothyroxine formulation with carrageenan
06/26/2014WO2014098764A1 Topical treatment delivery system
06/26/2014WO2014098624A1 Veterinary injectable formulations
06/26/2014WO2014098619A1 Transdermal parasiticidal formulations
06/26/2014WO2014098232A1 Pharmaceutical composition comprising pi3 kinase inhibitor, pharmaceutical composition comprising compound which acts on vitamin d receptor, freeze-dried composition, method for producing freeze-dried composition, and pharmaceutical composition for transpulmonary administration
06/26/2014WO2014098190A1 Composition and food or drink
06/26/2014WO2014097664A1 Colon delivery capsule and method for producing same
06/26/2014WO2014097302A1 A gellan gum carrier for a medicament, means and method
06/26/2014WO2014096985A2 A stable aqueous composition comprising human insulin or an analogue or derivative thereof
06/26/2014WO2014096863A1 Method for Quantifying the Characteristics of an Object treated with a Contrast Agent
06/26/2014WO2014096740A1 Pharmaceutical composition in the form of an oral suspension including a flavonoid fraction and xanthan gum
06/26/2014WO2014096595A1 Novel ampholytic polymers having a thermosensitive character
06/26/2014WO2014096551A1 Linker-payload molecule conjugates
06/26/2014WO2014096368A1 Pyrrolobenzodiazepines and conjugates thereof
06/26/2014WO2014096367A1 Expression of beta2-microglobulin as a prognostic marker for tumour immune escape and resistance to cancer immunotherapy and a diagnostic biomarker for patient selection for specific gene therapy
06/26/2014WO2014096139A1 Solid oral dosage form of testosterone derivative
06/26/2014WO2014096116A1 Pharmaceutical formulation comprising ciclesonide
06/26/2014WO2014095953A1 Dialysis composition
06/26/2014WO2014095920A1 New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity
06/26/2014WO2014095915A1 Chain-extending poloxamers, thermoreversible hydrogels formed by them which include biological materials, and medicinal applications of same
06/26/2014WO2014095705A1 Gel compositions
06/26/2014WO2014095602A1 Combination of levocabastine and fluticasone furoate for the treatment of inflammatory and/or allergic conditions
06/26/2014WO2014095485A1 Silymarin aqueous formulation
06/26/2014WO2014095062A1 Hyaluronic acid - antioxidant conjugates and their uses
06/26/2014WO2014094956A1 Magnesium hydroxide carbonate as excipient in pharmaceutical preparations, having improved release of active ingredient
06/26/2014WO2014094799A1 Ubiquitin moieties as a means for prolonging serum half-life
06/26/2014WO2014094539A1 Aba-type triblock copolymer based on molecular glue, synthesis therefor, and use thereof
06/26/2014WO2014094527A1 Compounds and methods for the treatment of erb b2/neu positive diseases
06/26/2014WO2014094355A1 Compounds and methods for the treatment of egfr positive diseases
06/26/2014WO2014094353A1 Maytansinoid derivatives
06/26/2014WO2014094127A1 Internal ultrasound gel
06/26/2014WO2014054978A3 Stable combined solution of fenoterol hydrobromide and ipratropium bromide
06/26/2014WO2013090891A8 Controlled release vehicles having desired void volume architectures
06/26/2014US20140179906 Conjugation methods
06/26/2014US20140179902 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
06/26/2014US20140179900 Treatment of atherosclerosis with cholesterol ester transport protein mimotopes
06/26/2014US20140179877 Macromolecule conjugate
06/26/2014US20140179825 Methods Of Manufacturing Contact Lenses For Delivery Of Beneficial Agents
06/26/2014US20140179803 Continuous flow production of gelatin nanoparticles
06/26/2014US20140179802 Fiber comprising a biodegradable polymer
06/26/2014US20140179795 Agent for Stabilizing Acetaminophen
06/26/2014US20140179784 Levothyroxine formulation with carrageenan
06/26/2014US20140179783 Citrulline-containing beverage
06/26/2014US20140179761 Targeting lipids
06/26/2014US20140179745 Topical ophthalmological pharmaceutical composition containing regorafenib
06/26/2014US20140179739 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
06/26/2014US20140179721 Solid pharmaceutical dosage form
06/26/2014US20140179712 Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
06/26/2014US20140179655 Solid oral dosage form of testosterone derivative
06/26/2014US20140179650 Pharmaceutical formulation comprising ciclesonide
06/26/2014US20140179633 Composition comprising pyrazino-triazine derivatives
06/26/2014US20140179621 Methods for Treating or Preventing Ophthalmological Diseases
06/26/2014US20140179605 Natriuretic polypeptide delivery systems
06/26/2014US20140179600 Stable formulations for parenteral injection of peptide drugs
06/26/2014US20140179599 Stable formulations for parenteral injection of peptide drugs
06/26/2014US20140179592 Compounds
06/26/2014US20140178508 Stabilized anthocyanin compositions
06/26/2014US20140178497 Thrush treatment paste
06/26/2014US20140178486 Cancer treatements
06/26/2014US20140178480 Safety of psuedoephedrine drug products
06/26/2014US20140178475 Therapeutic Nanoparticles Comprising a Therapeutic Agent and Methods of Making and Using Same
06/26/2014US20140178462 Amphoteric liposomes comprising neutral lipids
06/26/2014US20140178455 Gradient Porous Scaffolds
06/26/2014US20140178451 Activators of cxcr3 for the treatment of angiopathies of the eye
06/26/2014US20140178427 Total polysaccharides of radix isatidis and their fractions, and uses thereof as vaccine adjuvants
06/26/2014US20140178417 Methods for treating cancer using an immunotoxin
06/26/2014US20140178415 Maytansinoid derivatives
06/26/2014US20140178413 Compounds and methods for the treatment of erb b2/neu positive diseases
06/26/2014US20140178412 Compounds and methods for the treatment of egfr positive diseases
06/26/2014US20140178411 Compounds and methods for the treatment of cd20 positive diseases
06/26/2014US20140178383 Stable formulations of polypeptides and uses thereof
06/26/2014US20140178380 Bi-Specific Fusion Proteins
06/26/2014US20140178377 Methods and compositions for treatment of myotonic dystrophy
06/26/2014US20140178356 Stabilised Solid Compositions of Factor VII Polypeptides
1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 1712